Itron (ITRI) director amends Form 4 stock grant details
Rhea-AI Filing Summary
Itron, Inc. reported an amended insider filing for a board member. On 01/02/2026, an independent director received a grant of 555 shares of Itron common stock as part of the quarterly equity compensation that independent members of the board receive for their service. The shares were granted at a stated price of $0, reflecting that this was board compensation rather than an open‑market purchase.
Following this grant and the correction, the director beneficially owns 9,564 shares of Itron common stock. The amendment explains that 26 shares were previously omitted due to an arithmetic error and are now included in the reported holdings.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Itron (ITRI) report in this Form 4/A?
The filing reports that an independent Itron director received a grant of 555 shares of common stock on 01/02/2026 as part of regular quarterly board compensation.
Why was this Itron (ITRI) Form 4/A filed as an amendment?
The amendment states it is being filed to include 26 shares that were inadvertently omitted earlier due to an arithmetic error.
How many Itron shares does the director own after this transaction?
After the reported grant and correction, the director beneficially owns 9,564 shares of Itron common stock.
What price was reported for the Itron stock grant to the director?
The 555-share grant of Itron common stock was reported at a price of $0, consistent with stock issued as compensation for board service.
Is the reported Itron insider a director, officer, or 10% owner?
The reporting person is identified as a director of Itron, Inc., and the form indicates it is filed by one reporting person.
How often do Itron independent directors receive stock grants like this?
The explanation notes that independent members of Itron's board receive common stock quarterly as part of their annual compensation for board service.